South African arm wins $168 mn drug order over 4 yrs: Cipla
| Nov 30, 2012, 10:07:19 AM
Share
Cipla's EPS-accretive acquisition of a 51 per cent stake in Cipla Medpro will enable it to build a front-end in its key market of Africa (where it earns 40 per cent of its revenues) and gain the third-largest position in the South African pharma market.